Annual EBIT
-$8.24 M
+$343.30 K+4.00%
30 June 2024
Summary:
NanoViricides annual earnings before interest & taxes is currently -$8.24 million, with the most recent change of +$343.30 thousand (+4.00%) on 30 June 2024. During the last 3 years, it has risen by +$492.50 thousand (+5.64%). NNVC annual EBIT is now -606.78% below its all-time high of $1.93 million.NNVC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$3.13 M
-$770.80 K-32.72%
01 September 2024
Summary:
NanoViricides quarterly earnings before interest & taxes is currently -$3.13 million, with the most recent change of -$770.80 thousand (-32.72%) on 01 September 2024. Over the past year, it has dropped by -$1.03 million (-48.78%). NNVC quarterly EBIT is now -177.21% below its all-time high of $4.05 million, reached on 31 March 2014.NNVC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$9.44 M
-$1.19 M-14.49%
01 September 2024
Summary:
NanoViricides TTM earnings before interest & taxes is currently -$9.44 million, with the most recent change of -$1.19 million (-14.49%) on 01 September 2024. Over the past year, it has dropped by -$132.20 thousand (-1.42%). NNVC TTM EBIT is now -786.67% below its all-time high of $1.37 million, reached on 30 June 2015.NNVC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NNVC EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.0% | -48.8% | -1.4% |
| 3 y3 years | +5.6% | -63.0% | -8.4% |
| 5 y5 years | +2.1% | -62.6% | -20.4% |
NNVC EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.8% | +5.6% | -99.2% | +12.4% | -38.8% | +0.2% |
| 5 y | 5 years | -1.8% | +38.3% | -99.2% | +61.1% | -38.8% | +34.6% |
| alltime | all time | -606.8% | +38.3% | -177.2% | +61.1% | -786.7% | +34.6% |
NanoViricides EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.13 M(+32.7%) | -$9.44 M(+14.5%) |
| June 2024 | -$8.24 M(-4.0%) | -$2.36 M(+27.0%) | -$8.24 M(-12.8%) |
| Mar 2024 | - | -$1.85 M(-11.8%) | -$9.46 M(+1.6%) |
| Dec 2023 | - | -$2.10 M(+8.8%) | -$9.31 M(+4.0%) |
| Sept 2023 | - | -$1.93 M(-45.9%) | -$8.95 M(+4.2%) |
| June 2023 | -$8.59 M(+6.0%) | -$3.57 M(+109.7%) | -$8.59 M(+26.3%) |
| Mar 2023 | - | -$1.70 M(-2.4%) | -$6.80 M(-1.2%) |
| Dec 2022 | - | -$1.75 M(+11.2%) | -$6.88 M(-2.5%) |
| Sept 2022 | - | -$1.57 M(-11.9%) | -$7.06 M(-12.9%) |
| June 2022 | -$8.10 M(-7.3%) | -$1.78 M(-0.4%) | -$8.10 M(-3.4%) |
| Mar 2022 | - | -$1.79 M(-6.8%) | -$8.38 M(-3.7%) |
| Dec 2021 | - | -$1.92 M(-26.6%) | -$8.70 M(-4.1%) |
| Sept 2021 | - | -$2.61 M(+26.5%) | -$9.08 M(+3.9%) |
| June 2021 | -$8.74 M(-34.6%) | -$2.06 M(-2.0%) | -$8.73 M(+2.8%) |
| Mar 2021 | - | -$2.11 M(-8.1%) | -$8.50 M(-41.1%) |
| Dec 2020 | - | -$2.29 M(+1.1%) | -$14.43 M(+2.6%) |
| Sept 2020 | - | -$2.27 M(+23.9%) | -$14.06 M(+5.3%) |
| June 2020 | -$13.35 M(+58.5%) | -$1.83 M(-77.2%) | -$13.35 M(-2.8%) |
| Mar 2020 | - | -$8.04 M(+317.9%) | -$13.74 M(+75.3%) |
| Dec 2019 | - | -$1.92 M(+23.2%) | -$7.84 M(-3.8%) |
| Sept 2019 | - | -$1.56 M(-29.4%) | -$8.14 M(-5.5%) |
| June 2019 | -$8.42 M(+5.1%) | -$2.21 M(+3.4%) | -$8.62 M(+7.0%) |
| Mar 2019 | - | -$2.14 M(-4.1%) | -$8.06 M(+0.4%) |
| Dec 2018 | - | -$2.23 M(+9.4%) | -$8.03 M(-4.6%) |
| Sept 2018 | - | -$2.04 M(+23.5%) | -$8.42 M(+5.0%) |
| June 2018 | -$8.02 M(-1.9%) | -$1.65 M(-21.8%) | -$8.02 M(-6.5%) |
| Mar 2018 | - | -$2.11 M(-19.4%) | -$8.58 M(-6.2%) |
| Dec 2017 | - | -$2.62 M(+59.4%) | -$9.14 M(+23.5%) |
| Sept 2017 | - | -$1.64 M(-25.7%) | -$7.40 M(-9.4%) |
| June 2017 | -$8.18 M(-1.0%) | -$2.21 M(-17.4%) | -$8.18 M(+17.0%) |
| Mar 2017 | - | -$2.68 M(+204.7%) | -$6.99 M(-19.1%) |
| Dec 2016 | - | -$878.10 K(-63.6%) | -$8.64 M(-13.1%) |
| Sept 2016 | - | -$2.41 M(+136.8%) | -$9.94 M(+20.4%) |
| June 2016 | -$8.25 M(-607.4%) | -$1.02 M(-76.5%) | -$8.25 M(+8.5%) |
| Mar 2016 | - | -$4.33 M(+98.9%) | -$7.61 M(+479.2%) |
| Dec 2015 | - | -$2.18 M(+198.8%) | -$1.31 M(+191.7%) |
| Sept 2015 | - | -$728.20 K(+93.7%) | -$450.30 K(-132.8%) |
| June 2015 | $1.63 M | -$375.90 K(-119.1%) | $1.37 M(-130.1%) |
| Mar 2015 | - | $1.97 M(-249.8%) | -$4.56 M(+84.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | - | -$1.31 M(-219.7%) | -$2.48 M(+3.1%) |
| Sept 2014 | - | $1.10 M(-117.4%) | -$2.40 M(-75.5%) |
| June 2014 | -$9.94 M(+27.7%) | -$6.31 M(-255.8%) | -$9.80 M(+83.1%) |
| Mar 2014 | - | $4.05 M(-427.1%) | -$5.35 M(-56.3%) |
| Dec 2013 | - | -$1.24 M(-80.4%) | -$12.26 M(-0.0%) |
| Sept 2013 | - | -$6.31 M(+239.0%) | -$12.27 M(+57.9%) |
| June 2013 | -$7.78 M(+25.4%) | -$1.86 M(-35.0%) | -$7.77 M(+2.9%) |
| Mar 2013 | - | -$2.86 M(+130.0%) | -$7.55 M(+12.3%) |
| Dec 2012 | - | -$1.24 M(-31.1%) | -$6.72 M(-1.4%) |
| Sept 2012 | - | -$1.80 M(+9.7%) | -$6.82 M(+10.8%) |
| June 2012 | -$6.21 M(-4.2%) | -$1.64 M(-19.1%) | -$6.15 M(+5.8%) |
| Mar 2012 | - | -$2.03 M(+52.0%) | -$5.82 M(-8.3%) |
| Dec 2011 | - | -$1.34 M(+17.2%) | -$6.34 M(-2.5%) |
| Sept 2011 | - | -$1.14 M(-12.9%) | -$6.51 M(+0.4%) |
| June 2011 | -$6.48 M(+31.1%) | -$1.31 M(-48.8%) | -$6.48 M(+7.5%) |
| Mar 2011 | - | -$2.56 M(+70.6%) | -$6.02 M(+2.3%) |
| Dec 2010 | - | -$1.50 M(+34.9%) | -$5.89 M(+10.8%) |
| Sept 2010 | - | -$1.11 M(+29.8%) | -$5.32 M(+7.7%) |
| June 2010 | -$4.94 M(+75.2%) | -$856.20 K(-64.7%) | -$4.94 M(+4.9%) |
| Mar 2010 | - | -$2.43 M(+162.1%) | -$4.71 M(+53.1%) |
| Dec 2009 | - | -$925.40 K(+26.6%) | -$3.08 M(+10.1%) |
| Sept 2009 | - | -$731.20 K(+16.7%) | -$2.79 M(-0.9%) |
| June 2009 | -$2.82 M(+1.0%) | -$626.40 K(-20.9%) | -$2.82 M(-11.7%) |
| Mar 2009 | - | -$792.00 K(+22.9%) | -$3.19 M(-0.4%) |
| Dec 2008 | - | -$644.50 K(-14.8%) | -$3.21 M(+8.1%) |
| Sept 2008 | - | -$756.80 K(-24.2%) | -$2.97 M(+6.2%) |
| June 2008 | -$2.79 M(-9.4%) | -$998.90 K(+24.0%) | -$2.79 M(+8.7%) |
| Mar 2008 | - | -$805.30 K(+98.7%) | -$2.57 M(-4.6%) |
| Dec 2007 | - | -$405.20 K(-30.4%) | -$2.69 M(-10.1%) |
| Sept 2007 | - | -$582.60 K(-24.8%) | -$2.99 M(-2.9%) |
| June 2007 | -$3.08 M(+18.8%) | -$774.90 K(-16.5%) | -$3.08 M(-10.1%) |
| Mar 2007 | - | -$928.40 K(+31.4%) | -$3.43 M(+4.3%) |
| Dec 2006 | - | -$706.60 K(+5.0%) | -$3.29 M(-6.1%) |
| Sept 2006 | - | -$673.00 K(-39.9%) | -$3.50 M(+6.6%) |
| June 2006 | -$2.60 M(+3833.0%) | -$1.12 M(+42.0%) | -$3.28 M(+51.7%) |
| Mar 2006 | - | -$788.40 K(-14.2%) | -$2.16 M(+57.3%) |
| Dec 2005 | - | -$919.10 K(+101.1%) | -$1.38 M(+201.1%) |
| Sept 2005 | - | -$457.00 K | -$457.00 K |
| June 2005 | -$66.00 K | - | - |
FAQ
- What is NanoViricides annual earnings before interest & taxes?
- What is the all time high annual EBIT for NanoViricides?
- What is NanoViricides annual EBIT year-on-year change?
- What is NanoViricides quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for NanoViricides?
- What is NanoViricides quarterly EBIT year-on-year change?
- What is NanoViricides TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for NanoViricides?
- What is NanoViricides TTM EBIT year-on-year change?
What is NanoViricides annual earnings before interest & taxes?
The current annual EBIT of NNVC is -$8.24 M
What is the all time high annual EBIT for NanoViricides?
NanoViricides all-time high annual earnings before interest & taxes is $1.93 M
What is NanoViricides annual EBIT year-on-year change?
Over the past year, NNVC annual earnings before interest & taxes has changed by +$343.30 K (+4.00%)
What is NanoViricides quarterly earnings before interest & taxes?
The current quarterly EBIT of NNVC is -$3.13 M
What is the all time high quarterly EBIT for NanoViricides?
NanoViricides all-time high quarterly earnings before interest & taxes is $4.05 M
What is NanoViricides quarterly EBIT year-on-year change?
Over the past year, NNVC quarterly earnings before interest & taxes has changed by -$1.03 M (-48.78%)
What is NanoViricides TTM earnings before interest & taxes?
The current TTM EBIT of NNVC is -$9.44 M
What is the all time high TTM EBIT for NanoViricides?
NanoViricides all-time high TTM earnings before interest & taxes is $1.37 M
What is NanoViricides TTM EBIT year-on-year change?
Over the past year, NNVC TTM earnings before interest & taxes has changed by -$132.20 K (-1.42%)